Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Signs of activity seen with PTC-299 in metastatic breast cancer patients

Oct. 15, 2009

Dapagliflozin improves glycemic control in type 2 diabetes patients and in preclinical models

Oct. 15, 2009

Sulindac exhibits protection against myocardial ischemic damage in preclinical study

Oct. 14, 2009

Re-engineered ABY-025 shows specific HER2 binding, favorable biodistribution

Oct. 14, 2009

Recent clinical data show advantages of alogliptin plus pioglitazone combination

Oct. 14, 2009

Liraglutide shows advantages over glimepiride in LEAD-2 type 2 diabetes study

Oct. 14, 2009

Dalcetrapib effective and well tolerated in diabetes and metabolic syndrome patients

Oct. 14, 2009

Data show Afresa efficacy in diabetes with no significant effects on lung function

Oct. 14, 2009

Antibacterial activity of razupenem further detailed in vitro and in vivo

Oct. 14, 2009

In vivo data suggest high drug load delivery of 259C/MBX-500 via emulsion formulation

Oct. 14, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...